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Abstract 
Early rectal cancer management includes tumour stages 
TiS, T1 and some selected T2 lesions that undergo 
appropriate clinical pre-operatie evaluation. Local 
excision of these lesions with acceptable recurrence rate 
can be achieved through various transanal endoscopic 
techniques like transanal endoscopic microsurgery (TEM) 
and transanal minimal invasive surgery (TAMIS) that are 
superior to simple transanal excision (TAE). The current 
literature review was planned to present the oncological 
evaluation of local excision in the context of available 
evidence. An overview of perioperative adjuvant 
therapies employed along with local excision is 
presented, with an update on the latest trials. 
Keywords: Rectal cancer, Early rectal cancer, Transanal 
endoscopic microsurgery, TEM, Transanal minimally 




The ideal treatment of rectal cancer would aim to achieve 
long-term survival with effective disease control and at 
the same time preserve anal sphincter continence with 
optimal function. The standard of care in rectal cancer 
surgery is Total Mesorectal Excision (TME), but it comes 
with a high rate of morbidity, sexual dysfunction, and 
other complications, including anastomotic leaks 
following restoration of bowel continuity.1 Histologically, 
radical resection like TME was advocated for all tumours 
which invaded sub-mucosal layer and beyond, whereas 
the type of curative surgery varied depending on the 
location of the tumour in the rectum i.e., anterior 
resection for upper / middle and low positions, and 
abdomino-perineal resection for very low rectal lesions 
with end colostomy.2 Local tumour recurrence rate for 
stage 1 cancers after radical resection was noted to be 
very low at 5-8%.3 
Local Excision (LE) of Early Rectal Cancers (ERCs) is a less 
invasive option compared to radical surgery with closer 
resection margins and lesser morbidity.4 Along with the 
benefits of LE, potential higher cure rates for ERC can be 
achieved provided the patient selection and disease 
staging process is accurate.  
We have not found any published data on minimal 
invasive intervention in ERC in Pakistan in any medical 
literature search engine, including PubMed, Cochrane, 
Ovid, Web of Science, Science Direct, Scopus, Cochrane 
library, and Google Scholar. 
The current qualitative narrative review article was 
planned using Standards for Reporting Qualitative 
Research.5 
Early Rectal Cancer 
Definition 
United Kingdom's National Bowel Cancer Screening 
programme has identified that over 70% of the cancers 
were left-sided and early, including polyp cancers (10%) 
and Duke's A or B at 30%.6 Consensus statements from 
the European Association for Endoscopic Surgery (EAES) 
in 2014 defined what constitutes ERC. 'ERC is defined as a 
rectal cancer with good prognostic features that might be 
safely removed preserving the rectum and that will have 
a very limited risk of relapse after local excision'.7 
Obviously there are other modalities through which ERC 
can be defined i.e., Tumour, Node, Metastasis (TNM) 
staging, Haggitt levels (1-4) for pedunculated lesions and 
Kikuchi classification for flat lesions (Figure-1).8 Kikuchi, 
through his classification process, divides the sub-mucosa 
into sm1-sm3 depending upon the submucosal invasion 
of the tumour. All ERC lesions usually have minimal risk of 
lymph node (LN) metastasis, i.e., sm1-2%, sm2-8%, 
whereas stage T1 sm3 classified lesions can have positive 
LN spread up to 23%.9 
Staging Process 
Accurate ERC staging is crucial for making an appropriate 
local excision management plan. Modalities that are used 
in the process of staging include clinical examination, 
endoscopic evaluation and radiological investigations. 
Clinical Examination: Since LE can only be undertaken 
for lesions within 20cm of the anal verge, physical 
examination of the patient becomes very important. This 
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process in the surgical clinic should include Digital Rectal 
Examination (DRE) and Rigid proctoscopy (RP) / 
sigmoidoscopy (RS) by the operating surgeon to assess 
the distance of the tumour from the anal verge, its 
position and mobility (tethered or fixed) and its hardness. 
Position of the tumour (anterior / posterior / lateral) 
within the bowel wall and its relation to sphincter 
complex will allow the multidisciplinary team (MDT) to 
make informed decisions about sphincter preservation 
versus abdomino-perineal resection. Even though 
colonoscopy is considered the gold standard for 
detecting colorectal cancers, its accuracy for precise 
tumour localisation within the pelvis has been found to 
be inferior to RS. Similarly, computed tomography (CT) 
and magnetic resonance imaging (MRI) indicate more 
accurately than RS whether the tumour is intra- or extra-
peritoneal, thus determining the future use of neo-
adjuvant chemoradiotherapy (CRT).9 
Endoscopic Evaluation: Nowadays macroscopic and 
microscopic features of the lesion can be captured 
through advanced colonoscopy and this will help in 
endoscopic staging of ERC. A detailed and revised Paris 
classification is increasingly used to evaluate polyps 
(stalked and flat) along with narrow band imaging (NBI) 
International Colorectal Endoscopic (NICE) classification 
and magnifying chromoendoscpy (MCE).10,11 With these 
tools one can differentiate between 3 types of lesions 
based on the colour, surface pattern and vasculature: 
hyperplastic, adenomatous, and invasive.10 MCE has been 
found to be the best indicator of pit pattern which makes 
it the most reliable method that can be used to identify 
neoplastic lesions and its depth of invasion.11 
The SANO classification, which uses mucosal capillary 
pattern to distinguish between intra-mucosal and 
invasive cancers, has high sensitivity and specificity of 
over 95%.11 Taking biopsy during endoscopic assessment 
for polyps is found to be detrimental for future excision of 
the lesion due to fibrosis and non-lifting sign.11,12 Pre- or 
post-operative complete colonoscopic assessment of the 
bowel is necessary to rule out synchronous tumours or 
polyps as their incidence is 4% and 30% respectively.13 
Endorectal ultrasound (ERUS) is a good modality of 
investigation for differentiation of T1 and T2 rectal 
tumours, but at the same time ERUS cannot identify T1 
lesions into sm1, sm2, or sm3. ERUS and MRI scan when 
employed in conjunction can lead to in-depth staging of 
the primary tumour with accurate determination of local 
mesorectal lymph node metastasis.14 
The ultrasonographic staging corresponding to TNM 
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Figure-1: Staging of early rectal cancer, Hagitt's and Kikuchi classifications.
stage 0 (T0/Tis) corresponds to carcinoma in situ confined 
to muscularis mucosa; stage 1 or IIIA (T1) tumours invade 
submucosa but don't invade muscularis propria; stage 1, 
IIIA, IIIB (T2) means tumour invading muscularis propria; 
stage IIA or IIIB (T3) means tumour invading beyond 
muscularis propria or infiltrating perirectal fat, and stage 
IIA, IIC or IIIB (T4) means tumour infiltrating surrounding 
organs. Stage IIIC and IV are reserved for N2M0 and NXM1 
respectively.15,16 
CT of the patient will provide staging on distant 
metastasis and all three modalities (ERUS / MRI / CT) when 
used together in an efficient manner will lead to near-
accurate staging of the disease.16 
The final histology report after LE can only confirm the 
true stage of the tumour and its associated histological 
features determine the risk of lymph node metastasis 
(LNM), hence LE must be considered as complete excision 
biopsy of the lesion which will help to determine any 
need for further additional treatment (CRT / 
chemotherapy).17 
Patient Selection 
Every patient is eligible for LE provided he meets the 
criteria of ERC with no evidence of invasion into 
muscularis layer and LN spread.  
Location and size: Tumour should be mobile / non-fixed 
and within 20cms of the anal verge. Lesion should be 
<50% of the circumference of the rectal wall. Lesion size 
must not exceed 4cm. 
Staging investigations: Standard staging investigation 
required in ERC treatment includes ERUS, colonoscopy, 
MRI and CT. For some cases, completion colonoscopy can 
be carried out after LE. Tumour must be either T1 or ERC 
with no LN disease. 
Pre-operative biopsy: There is presence of well or 
moderate differentiation of tumour cells with no lympho-
vascular / perineural invasion (T1 sm1 or T1 sm2), and no 
features of tumour budding. 
Other Indications: After Endoscopic Mucosal Resection 
(EMR) / Endoscopic Sub-Mucosal Dissection (ESD) 
procedures for incompletely excised polyps or positive 
resection margins are seen. Difficult access lesions on 
lower gastrointestinal (GI) endoscopy and choice of 
patients and palliative intent only are included. 
Sometimes patients with advanced tumours can choose 
to have LE because of their co-morbidity and for personal 
reasons (stoma stigma). When oncological treatment is 
compromised due to patient choice, the reasons for local 
resection need to be clearly documented after discussion 
with the patient. 
Early Rectal Cancer (ERC) Treatment 
ERC is mainly treated in two separate ways  
1) Endoscopy  
2) Local Excision 
Endoscopy 
Colonoscopy is used with a simple snare device to excise 
small pedunculated or stalked polyp with little difficulty. 
EMR is usually used for sessile or flat lesions which are 
<2cm in size and confined to superficial layers of the 
bowel (mucosa / sub-mucosa). Three different techniques 
are available for the endoscopist, including injection, cap 
and ligation-assisted EMR. The technique essentially 
involves injecting saline into sub-mucosal space and 
creating a 'safety cushion' for electro-cautery device used 
and the cushion protects the deeper structures in the 
mesorectum from thermal damage. 
Endoscopic Sub-Mucosal Dissection (ESD) is used for 
lesions >2cm and it is a more complex procedure to 
master. EMR / ESD for malignant lesions which are non-
lifting, serrated polyps, is usually attempted with caution. 
Local Excision (LE) 
Local excision can be defined as organ-preserving 
strategy which involves minimal dissection of the early 
rectal cancer with good resection margins. Rectal 
dissection can be carried out in sub-mucosal fashion for 
benign lesions and full thickness for neoplastic or 
malignant lesions. 
LE can be carried out in multiple diverse ways: Transanal 
excision (TAE), Transanal Endoscopic Microsurgery (TEM), 
and Transanal Minimally Invasive Surgery (TAMIS). 
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Table-1: Association of Coloproctology of Great Britain and Ireland (ACPGBI) 2015. 
 
Polyp                                                               POLYP SIZE (mm) 
Classification         <5                 6- 10                11- 15                16 - 20                  >20 
 
Ip                                   SS                     SS                        SS                          SS                         SS 
Is                              SS/ EMR             EMR                   EMR                      EMR                    pEMR 
IIa, b; IIa+b              EMR                 EMR               EMR/ESD          ESD/Surgery          Surgery 
IIc                                 EMR            EMR/ESD            Surgery                Surgery               Surgery 
LST - G                           -                        -                       EMR                pEMR/ESD         pEMR/ESD 
LST -NG                         -                        -                  EMR/ESD                  ESD              ESD/Surgery 
 
EMR: Endoscopic Mucosal Resection; ESD: Endoscopic Sub-mucosal Dissection;  
LST-G: Lateral spreading tumour with granular surface; pEMR: Piecemeal Endoscopic Mucosal 
Resection 
SS: Simple snare; Surgery: Surgical excision.
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Since patients with no mesorectal disease (T2 or LN-
positive) show good outcomes in terms of local 
recurrence (LR) and overall survival (OS), during local 
excision care needs to be taken to avoid mesorectal tissue 
dissection. Any contamination of mesorectal fat during LE 
with tumour cells will lead to early recurrence and hence 
post-excision cavity must be washed with saline. The 
position statement on the management of colorectal 
lesions based on polyp size and morphology must be kept 
in mind (Table-1). 
Transanal Excision (TAE) 
This procedure is carried out after administering full 
bowel preparation and the patient is positioned in prone 
or lithotomy depending on the location of the tumour. 
Regional pudendal nerve block and general anaesthesia 
work very well for this procedure with good sphincter 
relaxation. Appropriate retractors and head-light source 
are used to excise lesion in the lower rectum and the 
defect is closed transversely with sutures after good 
washout of the area. Surgeons should aim at least 1cm 
circumferential margin around the lesion for achieving 
complete oncological excision. Patency of the anal canal 
and rectum is confirmed with a proctoscopy at the end of 
the procedure. This technique carries minimal risk of 
serious complications, like faecal incontinence, local 
sepsis, recto-vaginal fistula and stricture.18 
Transanal Endoscopic Microsurgery (TEM) 
First introduced by German surgeon Dr Gerhard Buess in 
1984, TEM is increasingly being used by other surgeons in 
the treatment of ERC.19 
TEM setup consists of insufflator machine which supplies 
carbon dioxide (CO2) continuously with suction facility. 
Operating rectoscope has a 4cm diameter with 
instrument port in varied sizes (short and long) to reach 
up to 20cm of rectal lumen. The specialised equipment for 
TEM also has modified laparoscopic camera / light source 
and instruments. It also comes with the adjustable handle 
through which the rectoscope is secured to the bed. TEM 
equipment's high investment cost and the procedure's 
steep learning curve probably reduced its popularity 
among surgeons. Since the movement of the operating 
instruments through the rectoscope is limited, the 
success of TEM procedure is based on how well the 
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Figure-2: Transanal Endoscopic Microsurgery (TEM) Rectoscope and operative field representation and lesions pinned out to show clear excision margins.
patient is positioned on the bed in relation to the lesion in 
the rectum i.e., lateral, lithotomy or prone. Even in obese 
patients with good positioning, excellent exposure of 
rectal lesions can be achieved. After LE of the lesion from 
the rectum, specimen should be pinned down onto the 
cork board to show the cut edge of the margins as they 
usually shrink and retract once placed inside formalin 
(Figure-2). 
TEM is a safe procedure like the traditional TAE with 
evidence pointing towards low complication rate and 
particularly no long-term adverse effect on anorectal 
function.19 Bleeding was the most common complication 
(27%) suture line dehiscence 14% and urinary tract 
infection 21%, while temporary faecal incontinence was 
around 1%.20 Surgeons who have performed more than 
35 TEM procedures tend to show lowered risk of 
recurrence for malignant lesions when compared to 
individuals who had operation under a less-experienced 
surgeon, and, hence, centralisation of services is 
essential.21 
Transanal Minimally Invasive Microsurgery 
(TAMIS) 
Another alternative for expensive TEM is TAMIS. It works 
on the same philosophy as TEM, but is less expensive as it 
uses most of the conventional laparoscopic kit like CO2 
insufflator and light source. The rectoscope of TEM is 
replaced by disposable short entry device which is like a 
Single Incision Laparoscopic Surgery (SILS) port. Although 
positioning of patient is paramount in TEM, it can offer 
only 220-degree view, whereas the TAMIS port gives 360-
degree view of the lumen.20 However, the continuous 
rectal insufflation in TEM is far superior compared to 
TAMIS. Lesions are dissected with 1cm margin and to 
decrease the gases released during TAMIS, it has been 
proposed to use ultrasonic electrocautery device instead 
of the traditional hook. Complication rates are 
comparable, and it has relatively easier learning curve 
when compared to TEM.21 
In TAE technique, the position of patient is tumour-
dependent and it could treat tumours up to 8cm from the 
dentate line. The cost is low and learning curve is 
moderate and 180-degree camera view is used. TEM uses 
220-degree camera views but it is expensive and the 
learning curve is steep and it could remove tumours 2-
15cm from the dentate line and the position of patient is 
tumour-dependent. In TAMIS the position of patient 
during procedure is in Llyod position and the cost is low. 
The learning curve is shallow, 360-degree camera is used 
and up to 15cm of tumour from the dentate line can be 
removed safely.  
TAMIS demonstrated low complication rate of 7.2% 
with tumour fragmentation at 4.1% and positive 
margin rate of 4.4%.21 
Oncological Outcomes for Local Excision 
Techniques: Transanal Excision (TAE) 
The results of LE for ERC have largely been restricted to 
small single-institution case reviews. The best study in the 
group is from American database for ERC management.22 
It is the biggest cohort study of 600 patients with tumour 
staged at T1 with a 5-year follow-up. It shows disease-free 
survival (DFS) of 93% and local recurrence rate of 8%. 
Studies on local excision of T1-staged ERC were 
published. Nash et al. in 2004 studied 137 patients and 
found 13% 5-year local recurrence rate and 83% 5-year 
DFS in 59-month follow-up.23 Da Graaf et al. in 2009 
published results of 80 patients and found 24% 5-year 
local recurrence rate and 90% 5-year DFS rate in 42-
month follow-up.24 You et al. in 2007 followed 601 
patients for 60 months and found 8.2% 5-year local 
recurrence and 93.2% 5-year DFS.22 Ptok et al. in 2007 and 
Bentrem et al. in 2005 studied 85 and 151 patients and 
found 6.0% and 15% 5-year local recurrence rate and 
91.4% and 93% 5-year DFS rate respectively.25,26 Similarly 
Endreseth et al. in 2005 and Nascimbeni et al. in 2004 
studied 35 and 70 patients for 60 and 54 months and 
found 12% and 6.6% 5-year local recurrence rate and 64% 
and 66.6% 5-year DFS rate respectively.26,27 
The range for 5-year local recurrence rate is as low as 6% 
and goes up to 24%.21-27 DFS also shows wide variation 
ranging from 64% to 93%. The wide variations in 
outcomes have been attributed to the poor quality of the 
studies. The factors which may have contributed to the 
poor quality are: 1) study involving heterogenous 
population, 2) inaccurate preoperative staging process, 3) 
evolving operative technique (non-standardised), and 4) 
cohorts including adjuvant therapy patients into the 
study. 
Studies of local excision of T2-staged ERCs are quite 
consistent. You et al. in 2007 included 164 patients and 
showed 13% local recurrence and 90% DFS rate, while 
Paty et al. in 2002 studied 51 patients and found 28% local 
recurrence and 87% DFS.21,27  
When TAE is compared to radical surgery such as TME, 
several studies have demonstrated higher local 
recurrence ranging from 6% to 24% for TAE and 2% to 
6% for TME, and thus TME confirmed its gold standard 
status in rectal cancer surgery (Table-2). These studies 
demonstrated outcomes following LE for T2-staged 
ERC, and clearly showed high recurrence rate for TAE 
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(13-28%). Similarly, You et al. also demonstrated 
higher rate of local recurrence of 12% in TAE 
compared to TME's 7.2%.22 
Outcomes for Transanal Endoscopic 
Microsurgery (TEM) 
Moore et al. in 2008 demonstrated that having an 
intact specimen with negative margin on histology 
gave TEM superiority over traditional TAE with low 
local recurrence rate of 4%.28 The reason for low 
recurrence rate in TEM procedure is due to its 
equipment which gives it better exposure than TAE. 
Studies comparing TEM versus TME23,24,28,29 (Table-3) 
have shown that radical surgery is still the better 
option to avoid local recurrence, whereas overall DFS 
is not hugely different. 
Radical Surgery and Adjuvant 
(Chemo)radiotherapy following Local 
excision (LE) 
After any LE technique for ERC, it is a well-known fact that 
some lesions are upstaged histologically to higher T stage 
or deemed high-risk due to poor differentiation of 
tumour, tumour budding, lympho-vascular invasion (LVI), 
or perineural invasion (PNI). Meta-analysis by Borstlap et 
al. in 2016 on treatment outcomes following LE for ERC 
gave good insight into the choices available for each 
patient depending on fitness and co-morbidity.29 
The crude local recurrence rate for combined T stages 1 
and 2 was 12.6% (51/405) with 17/117 for patients who 
underwent TEM and 34/288 for TAE LE group. Following 
adjuvant chemoradiotherapy (CRT), 3/60 pathology-T1 
(pT1) (5%) and 40/280 (14.3%) pT2 crude recurrence rate 
was observed. TME group following LE showed crude 
recurrence rate of 4.6% (6/130). Expectantly, T2 tumours 
had more recurrence than T1 (6% vs 4%). The 5-year DFS 
for both groups was >75%, whereas the OS rate was 61-
80% for CRT and 79-94% for completion TME group. 
Neo-Adjuvant Therapy and LE 
Locally advanced rectal cancer when treated with neo-
adjuvant therapy followed by radical TME surgery showed 
decreased local recurrence rates.30 To extrapolate, similar 
results in T2 or T3 tumours with LE instead of TME has 
been explored by several studies with improved tumour 
control.30,31 
Surveillance following LE 
Standard colorectal cancer surveillance protocol includes 
abdominal / rectal examination with CT imaging of chest 
/ abdomen / pelvis with regular carcinoembryonic 
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Table-2: Summary of studies comparing Local excision (LE) vs Total Mesorectal 
Excision (TME) surgery of T1-staged Early Rectal Cancer (ERC). 
 
TAE vs                                         Number       5-year Local            5-year             Follow up 
TME                                          of Patients     Recurrence      Disease Free      in months 
                                                                                  Rate (%)          Survival (%) 
 
Nash et al 200923                   TAE -  137                 13                            83                          59 
                                                     TME - 145                 2.7                           96                          77 
You et al 200722                      TAE -  601                 8.2                           93                          60 
                                                     TME - 493                 4.3                           97                          60 
Ptok et al 200725                      TAE -  85                    6                             91                          44 
                                                     TME - 359                   2                             92                           - 
Bentrem et al 200526            TAE -  151                 15                            93                          48 
                                                     TME - 168                   3                             97                          58 
Endreseth et al 200527           TAE -  35                   12                            64                          60 
                                                     TME - 256                   6                             77                          60 
De Graaf et al 200924              TAE -  80                   24                            90                          42 
                                                       TME - 75                    0                             87                          84 
 
Summary of studies comparing LE vs TME surgery of T2 staged Early Rectal Cancer (ERC) 
You et al 200722                            TAE -  164                12.6                          90                          60 
                                                     TME - 866                 7.2                           91                          60 
 
TAE: Transanal excision.
Table-3: Summary of studies comparing Transanal Endoscopic Microsurgery (TEM) vs Transanal Excision (TAE) () for Early Rectal Cancer (ERC) including T1/T2 & T3. 
 
TEM vs TAE                          Number of Patients              5-year Local Recurrence Rate (%)               Negative Margin (%)               Intact Specimen                 Follow up in months 
 
Moore et al, 2008.28                         TAE - 85                                                             24                                                                     71                                                   65                                                     53 
                                                                TEM - 35                                                              4                                                                      90                                                   94                                                     20 
 
Summary of studies comparing TEM vs Total Mesorectal Excision (TME) for Early Rectal Cancer (ERC) 
 
TEM vs TME                                  Number of Patients                   5-year Local Recurrence Rate (%)                    5-year Disease Free Survival (%)                         Follow up in months 
 
De Graaf et al 2009.24                              TEM - 80                                                                  24                                                                                      90                                                                              42 
                                                                        TME - 75                                                                   0                                                                                        87                                                                              84 
Ptok et al 2007.25                             TEM/TAE – 35/85                                             6.0 (TEM+TAE)                                                                          91                                                                              44 
                                                                       TME - 359                                                                  2                                                                                        92                                                                               -
antigen (CEA) levels and finally endoscopic surveillance. 
Based on the best evidence available in the literature, the 
following surveillance protocol is proposed, which is in 
line with the rectal cancer patients who achieved 
complete pathological response after neo-adjuvant 
CRT.31 Nash et al. demonstrated that if patients are 
followed up for longer periods of time, then there is 
increased local recurrence rate recorded.23 
Post-LE surveillance protocol 
In the first year after local excision, 3-monthly ERUS, MRI 
and Flexible sigmoidoscopy (FS), and CEA and CT 12-
monthly is recommended. In the second year, 6-monthly 
MRI, ERUS and FS, and CEA and CT 24-monthly is 
advisable. In the third to fifth years after local excision, 1-
yearly ERUS, MRI, FS, CEA and CT, and completion 
colonoscopy at 5 years is recommended. 
This protocol is followed step-wise provided the earlier 
surveillance did not yield any recurrence. After 2 years of 
rigorous follow-up of patients at tertiary / regional 
centres, patients can be handed back to the referral 
hospital with further follow-up plan. 
Future Perspectives 
Since there is big emphasis on pre-operative staging of 
ERC for better treatment outcomes, increasing capabilities 
of ERUS by using three-dimensional (3D) ERUS, which has 
been shown to visualise mesorectal fascia more accurately 
and yielding better T&N staging, is advisable. Similarly, 
colour Doppler ERUS can identify tumour angiogenesis 
and help in collecting the prognostic information. 
Treatment Trials: A Polish study group is conducting  a 
prospective multi-centre study involving rectal cancers 
staged T1-3 N0 with size <4cm involving preoperative 
radiotherapy and delayed LE with immediate re-
operation for poor responders.32 The Dutch CARTS 
(Transanal Endoscopic Microsurgery After 
Radiochemotherapy for Rectal Cancer) Study studied in 
2011CRT for distal rectal cancer followed by TEMS after 8-
10 weeks- within 10cms from the anal verge.33 The TREC 
(Transanal endoscopic microsurgery and radiotherapy in 
Early rectal Cancer) study will determine the feasibility of 
performing a RCT of radical TME surgery versus short 
course pre-operative radiotherapy (SCPRT) and delayed 
local excision at 8-10 weeks for T1-2N0M0 rectal cancer.34 
It is an open-ended, phase 2 multi-centre, prospective 
trial with recruitment outcomes measured at 12, 18 and 
24 months, including safety and efficacy of the above 
processes. STAR-TREC is a combined Single Phase 3 RCT 
involving CARTS group + TREC study group with the 
primary endpoint -being Standard Radical surgery vs 
Short Course Radiotherapy + TEM vs CRT and TEM.35 
Conclusion 
LE for early rectal cancer is a feasible option in highly 
selective patients. Obviously, the selection of patients will 
depend on the quality of preoperative staging process, 
which needs to be robust with high standard of accuracy. 
Depending on patients' preference and favourable 
histology features, LE and adjuvant therapy is a viable 
treatment option, although the overall oncological 
prognosis is inferior for LE when compared to standard 
TME. Strict post-treatment surveillance is essential 
irrespective of whichever LE approach needs to be 
followed. For high-risk T1 and low-risk T2, LE alone is 
generally not acceptable. 
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